Is First-Line Avelumab Effective for Metastatic Merkel Cell Carcinoma?

Investigators shared results of an interim analysis evaluating antitumor activity and safety in patients with mMCC receiving  avelumab monotherapy.

Source: CancerNetwork - November 14, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news